~~<i id='0757B946DB'><strike id='0757B946DB'><tt id='0757B946DB'><pre id='0757B946DB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：comprehensive 2025-08-31 20:56:48 - browse：7373

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Medicare slashes safety net hospital payments by nearly $1 billion

knowledge

hotspot

focus

Wikipedia

explore

focus

KristofferTripplaar/SipaviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toget

WSS

Gene therapy for Afghan refugees’ infant will be fully covered

Study links childhood stress with decline in older age

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Gene therapy for Afghan refugees’ infant will be fully covered

Alnylam reports growth in sales of rare disease treatments

focus

hotspot

knowledge

Medicare details structure of new drug price negotiation program

FDA approves Sage Therapeutics’ rapid

Novavax promises a turnaround & Lilly roils the obesity market

The a glaring gap in research on serious mental illness and primary care

The cancer drug shortage isn’t new — and neither are the solutions

Medicare slashes safety net hospital payments by nearly $1 billion

Jerome Adams on the need for new antivirals for Covid

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Alkermes shareholders re

Chris Christie meets with Zelenskyy during Ukraine trip

hotspot

FDA approves Sage Therapeutics’ rapid

Florida officials tell state schools to teach AP Psychology 'in its entirety'

CDC recommends RSV monoclonal antibody for infants

When waiting feels immoral: Empathy in the emergency department

How to ethically and practically extend health care to all

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

focus

Wikipedia

explore

focus